* Unit Released Top-Line Results From Phase II Trial Of
CF101 For The Treatment Of Glaucoma

The post BRIEF-Can Fite Biopharma says unit released Phase II top-line results of CF101 for treatment of Glaucoma appeared first on NASDAQ.